Pharmacy

Pharmacy benefit managers, the middlemen who negotiate drug benefits for health plans, will head to Capitol Hill this week to face back-to-back hearings about their role in the pricing of prescription drugs.

As opioid lawsuits against Purdue Pharma and its billionaire family owners mount, members of the Sackler family are leaving the governing boards of prominent nonprofit organizations, according to The Wall Street Journal.

Five private equity firms, including Apollo Global Management and CVC Capital Partners, are among the bidders for Perrigo's prescription drug unit, according to Bloomberg.

While designing their 2020 Medicare Part D plans, insurers and pharmacy benefit managers can assume rebates will still exist, CMS Administrator Seema Verma said in an April 5 memo.

A jury has decided that San Francisco-based Dignity Health must pay $3.4 million to a former outpatient pharmacy manager who claimed she was wrongly fired in 2015 for not fudging documents ahead of a federal probe, according to the Sacramento…

Here are 10 hospitals and health systems that posted job listings for pharmacy leaders in the last week.

FDA Commissioner Scott Gottlieb will step down from his position April 5. Below are four things to know about the departing FDA chief:

The FDA published a list April 4 of 40 generic blood pressure drugs that are free of potential cancer-causing impurities.

Three drugmakers — Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals — have agreed to pay $122.6 million to resolve allegations of violating the Anti-Kickback Statute by illegally using copay assistance programs.

The FDA sent 21 letters to stem cell clinics and manufacturers April 3, chastising them for not doing enough to comply with its regulations.